IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

MOLSON COORS BEVERAGE CO (TAP)

Business Summary

Molson Coors Beverage Company operates in the global brewing and broader alcohol industry, which has significantly evolved over the years to become an increasingly consolidated global beer market where a small number of large global brewers represent the majority of the worldwide beer market. The industry is highly competitive, and the company's portfolio of beers competes with numerous brands produced by international, national, regional, and local brewers. Consumer preferences have continued to shift within the industry to above premium products, with volume growth in recent years seen in flavored malt beverages, imports, and super premium portfolios, while consumers are also expanding into spirits, particularly spirits-based RTDs. The company believes large global brewers are uniquely positioned to leverage scale, depth of product portfolio, and industry knowledge to continue to lead the market forward.

The company is among the top five global brewers in the world. In the U.S. and Canada, it competes most directly with Anheuser-Busch InBev SA/NV and Constellation Brands, Inc., but also competes with imports and other providers of craft beer and flavored malt beverages. In European countries where it operates, primary competitors are Heineken, Asahi, Carlsberg, and ABI. Globally, its products also compete with other alcohol beverage categories, including wine, spirits, and wine-based and spirits-based RTDs. The company's competitive advantages include its brand portfolio, which gives it strong representation in all major beer categories, and its scale as one of the top five global brewers.

The company generates revenue through the production, importing, marketing, distribution, and sale of its owned brands, partner brands, and licensed brands across two reporting segments: the Americas and EMEA&APAC. Revenue is recognized at the point in time when control transfers to the customer, which is when the related goods are shipped or delivered. The company's primary revenue generating activity represents the sale of beer and other beverages to customers, who could be a distributor or a retailer depending on the market. The company also generates revenue from contract brewing arrangements, licensing agreements, and the sale of factored brands in the U.K., where it distributes beer, wine, spirits, and other products owned by other companies to the on-premise channel.

The Americas segment consists of the production, importing, marketing, distribution, and sales of owned brands, partner brands, and licensed brands in the U.S., Canada, and various countries in Latin America. The segment operates nine primary breweries, three craft breweries, and two container operations. Key owned brands include Coors Light, Miller Lite, Coors Banquet, Molson Canadian, and Blue Moon Belgian White, while partner brands include Simply Spiked, ZOA Energy, Fever-Tree, and Heineken. The segment also includes partnership arrangements with Brewers' Retail Inc. for distribution in Ontario and Brewers' Distributor Ltd. for distribution in western Canada. Net sales for the Americas segment were $8,712.8 million for the year ended December 31, 2025, compared to $9,240.2 million in the prior year. The Coors Light and Miller Lite brands in the Americas represented approximately 55% of segment net sales in 2025.

The EMEA&APAC segment consists of the production, marketing, and sales of owned brands, partner brands, and licensed brands in Bulgaria, Croatia, Czech Republic, Hungary, Montenegro, the Republic of Ireland, Romania, Serbia, the U.K., various other European countries, and certain countries within the Middle East, Africa, and Asia Pacific regions. The segment operates ten primary breweries, three craft breweries, and one cidery. Key owned brands include Carling, Staropramen, Coors, Madrí Excepcional, Ožujsko, and Bergenbier. The majority of segment sales are in the U.K., Croatia, Romania, and the Czech Republic, with the U.K. representing over 55% of the segment's net sales in 2025. Net sales for the EMEA&APAC segment were $2,455.7 million for the year ended December 31, 2025, compared to $2,411.1 million in the prior year. Carling, Staropramen, Coors, Madrí Excepcional, Ožujsko, and Bergenbier brands in EMEA&APAC represented approximately 45% of segment net sales in 2025.

On October 20, 2025, the company announced an Americas Restructuring Plan designed to create a leaner, more agile Americas organization, which resulted in charges of $28.7 million during the year ended December 31, 2025, primarily related to severance payments and post-employment benefits. During the first quarter of 2025, the company obtained exclusive rights via a license agreement to import, produce, market, advertise, promote, sell, and distribute Fever-Tree products in the U.S. and acquired the shares of Fevertree USA, Inc. During the year ended December 31, 2025, the company made an investment of $88.1 million in Fevertree Drinks plc. During the third quarter of 2025, the company recorded a partial goodwill impairment charge of $3,645.7 million related to the Americas reporting unit, a full impairment charge of $75.3 million related to the Blue Run Spirits definite-lived intangible asset, and a partial impairment charge of $198.6 million related to the Staropramen family of brands indefinite-lived intangible asset. During the year ended December 31, 2025, the company repurchased 6,895,630 shares of Class B common stock for an aggregate purchase price of approximately $647.9 million . On February 9, 2026, the Board approved an increase to the existing Class B common stock repurchase program by $2.0 billion , for an aggregate authorization of up to $4.0 billion , and an extension of the duration to December 31, 2031.

For the year ended December 31, 2025, the company reported net sales of $11,140.8 million , a decrease of 4.2% compared to $11,627.0 million in the prior year. Net loss attributable to MCBC was $2,139.6 million compared to net income of $1,122.4 million in the prior year. Diluted loss per share was $10.75 compared to diluted earnings per share of $5.35 in the prior year. The decrease in net sales was driven by lower financial volume of 8.6% , partially offset by favorable price and sales mix of 3.8% and favorable foreign currency impacts of 0.6% . The net loss was primarily driven by a $3,645.7 million partial goodwill impairment charge and intangible asset impairments of $273.9 million . Net cash provided by operating activities was $1,784.4 million for the year ended December 31, 2025.

Business Outlook & Financial Sufficiency

The company announced an Americas Restructuring Plan on October 20, 2025, and total restructuring charges are expected to be at the low end of the previously communicated range of $35 million to $50 million at approximately $35 million . The remaining charges, predominantly employee-related charges, for the Americas Restructuring Plan are expected to be recorded during the year ended December 31, 2026 . On February 18, 2026, the company announced a three-year cost savings program targeting up to $450 million with savings beginning in 2026, which is inclusive of the Americas Restructuring Plan and intended to mitigate inflation impacts and enable continued investments.

The company is focused on transforming even faster under the leadership of its new CEO, effective October 1, 2025, and is continuing its journey to become a total beverage company and putting itself on a path to sustainable growth. The company aims to champion beer at every turn while building a portfolio that reflects evolving preferences, concentrating on all segments of its beer portfolio and expanding into adjacent categories such as premium mixers, non-alcohol beverages, and energy drinks. The company's investments in technology, capabilities, partnerships, and innovation are designed to support profitable growth and diversification. The company plans to continue to innovate, test, and scale products, and relies on certain arrangements with partner brands for innovation, development, and growth in new products beyond beer.

The company's growth strategy includes premiumizing its portfolio and expanding beyond beer. The company obtained exclusive rights via a license agreement to import, produce, market, advertise, promote, sell, and distribute Fever-Tree products in the U.S. during the first quarter of 2025, which is aligned with its strategy to expand beyond the beer aisle. The company also has authorizations from Red Tree Beverages, LLC to produce, market, advertise, promote, sell, and distribute products bearing the Simply Spiked trademark in the U.S. and Canada, as well as the Topo Chico Hard Seltzer trademark in the U.S. Additionally, the company has an agreement with Heineken that grants it the right to produce, import, market, distribute, and sell certain Heineken products in Canada.

The company's cost of goods sold per hectoliter increased 5.8% for the year ended December 31, 2025, compared to prior year, primarily due to unfavorable mix driven by lower contract brewing volume in the Americas segment and premiumization, volume deleverage, cost inflation related to materials and manufacturing expenses including an approximate $35 million unfavorable impact to cost of goods sold attributable to Midwest Premium pricing, as well as unfavorable foreign currency impact, partially offset by cost savings initiatives. The company plans to continue to evaluate and implement strategies designed to help mitigate the impact on its business, consolidated results of operations, and financial condition while continuing to support its long-term strategic growth and capital allocation priorities.

The company initiated a multi-year implementation of a global ERP system beginning in the third quarter of 2025, intended to replace legacy operating and financial systems with a single global system. The company relies extensively on information services providers worldwide for its information technology functions and on internal networks and information systems to support a variety of business processes and activities, including brewing operations, procurement and supply chain, manufacturing, distribution, invoicing, and collection of payments. The company also utilizes cash pooling arrangements to facilitate access to cash across its geographies.

The company's Board approved a share repurchase program up to an aggregate of $2.0 billion of Class B common stock on September 29, 2023, with an expected program term of five years. On February 9, 2026, the Board approved an increase to the existing Class B common stock repurchase program by $2.0 billion , for an aggregate authorization of up to $4.0 billion , and an extension of the duration to December 31, 2031. Including this increase, approximately $2.6 billion remained available for repurchase under the Class B common stock repurchase program as of December 31, 2025. A quarterly dividend of $0.47 per share was declared and paid throughout 2025 for a total of $1.88 per share. On February 18, 2026, the Board declared a quarterly dividend of $0.48 per share. Capital expenditures incurred were $667.4 million for the year ended December 31, 2025.

The company faces headwinds from the global macroeconomic environment, including volatility due to global trade policies and other geopolitical events, which has resulted in heightened competitive activity and an associated reduction in market share of its products in certain segments. Tariff announcements in the U.S. in the second quarter of 2025 indirectly caused the price of the premium on aluminum in the U.S., known as the Midwest Premium, to spike and remain elevated, which resulted in an approximate $35 million unfavorable impact on results for the year ended December 31, 2025, and is expected to continue to adversely impact results of operations. The company also faces headwinds from changes in consumer preferences, including a shift toward non-alcoholic beverages, health and wellness trends, and the use of glucagon-like peptide (GLP-1) agonists.

The company faces constraints from the constant evolution of the global beer industry and the broader alcohol industry, and its position within these industries may fundamentally change. The company's Coors Light and Miller Lite brands in the Americas represented approximately 55% of segment net sales in 2025, while Carling, Staropramen, Coors, Madrí Excepcional, Ožujsko, and Bergenbier brands in EMEA&APAC represented approximately 45% of segment net sales in 2025, making the company disproportionately exposed to volatility in these markets. The company also faces constraints from the consolidation of independent distributors in the U.S., which could create a more challenging competitive landscape and hinder the distribution and sale of its products.

Management Sentiments & Priorities

Management's message emphasizes the company's transformation journey to become a total beverage company, with a focus on transforming even faster under the leadership of the new CEO, effective October 1, 2025. The key strategic priorities for the period ahead include continuing the journey to become a total beverage company, putting the company on a path to sustainable growth, and championing beer at every turn while building a portfolio that reflects evolving preferences. Management announced an Americas Restructuring Plan aimed at creating a leaner, more agile Americas organization while advancing the ability to reinvest in the business and position the company for future growth. The company also announced a three-year cost savings program targeting up to $450 million with savings beginning in 2026, intended to mitigate inflation impacts and enable continued investments at levels necessary to fuel the business.

Financial Details

For the year ended December 31, 2025, net sales were $11,140.8 million compared to $11,627.0 million in the prior year. Net loss attributable to MCBC was $2,139.6 million compared to net income of $1,122.4 million in the prior year. Diluted loss per share was $10.75 compared to diluted earnings per share of $5.35 in the prior year. Gross profit was $4,274.6 million compared to $4,533.4 million in the prior year. Operating loss was $2,336.9 million compared to operating income of $1,753.2 million in the prior year. Net cash provided by operating activities was $1,784.4 million compared to $1,910.3 million in the prior year. The company had cash and cash equivalents of $896.5 million as of December 31, 2025, compared to $969.3 million as of December 31, 2024. Total debt (current portion of long-term debt and short-term borrowings plus long-term debt) was $6,299.5 million as of December 31, 2025, compared to $6,146.1 million as of December 31, 2024. The reported results were materially affected by a $3,645.7 million partial goodwill impairment charge, intangible asset impairments of $273.9 million (including $198.6 million for Staropramen and $75.3 million for Blue Run Spirits), and restructuring charges of $28.7 million related to the Americas Restructuring Plan, all of which reduced reported net income. For the Americas segment, loss before income taxes was $2,343.6 million compared to income before income taxes of $1,523.3 million in the prior year. For the EMEA&APAC segment, loss before income taxes was $13.1 million compared to income before income taxes of $145.3 million in the prior year.

Risk Factors

The company faces material risk from the constant evolution of the global beer industry and broader alcohol industry, as its Coors Light and Miller Lite brands in the Americas represented approximately 55% of segment net sales in 2025, and any material shift in consumer preferences away from these brands could have a material adverse effect. The company is exposed to significant goodwill impairment risk, as the Americas reporting unit had $1.9 billion of goodwill remaining as of December 31, 2025, and its fair value exceeds its carrying value by less than 15% , making it at heightened risk of future impairment. The company faces material exposure to commodity price volatility, as the Midwest Premium on aluminum resulted in an approximate $35 million unfavorable impact on results for the year ended December 31, 2025, and is expected to continue to adversely impact results. The company is subject to risks from changes in trade policies, including tariffs, which have contributed to fluctuations in the price of aluminum and the Midwest Premium. The company also faces risks from the concentration of its net sales in mature markets, as net sales in the Americas segment accounted for approximately 78% of total 2025 net sales.

References

  1. [1] Item 7, MD&A — Segment Results of Operations, Americas Segment
  2. [2] Item 7, MD&A — Segment Results of Operations, Americas Segment
  3. [3] Item 1A, Risk Factors
  4. [4] Item 1, Business — EMEA&APAC Segment
  5. [5] Item 7, MD&A — Segment Results of Operations, EMEA&APAC Segment
  6. [6] Item 7, MD&A — Segment Results of Operations, EMEA&APAC Segment
  7. [7] Item 1A, Risk Factors
  8. [8] Item 7, MD&A — Items Affecting Reported Results, Americas Restructuring Plan
  9. [9] Item 8, Note 3 — Investments, ASC 321 Investment
  10. [10] Item 7, MD&A — Items Affecting Reported Results, Goodwill Impairment
  11. [11] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  12. [12] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  13. [13] Item 5, Issuer Purchases of Equity Securities
  14. [14] Item 8, Consolidated Statements of Cash Flows
  15. [15] Item 5, Issuer Purchases of Equity Securities
  16. [16] Item 5, Issuer Purchases of Equity Securities
  17. [17] Item 7, MD&A — Consolidated Results of Operations
  18. [18] Item 7, MD&A — Consolidated Results of Operations
  19. [19] Item 7, MD&A — Consolidated Results of Operations
  20. [20] Item 7, MD&A — Consolidated Results of Operations
  21. [21] Item 7, MD&A — Consolidated Results of Operations
  22. [22] Item 7, MD&A — Consolidated Results of Operations
  23. [23] Item 7, MD&A — Consolidated Results of Operations
  24. [24] Item 7, MD&A — Consolidated Results of Operations
  25. [25] Item 7, MD&A — Consolidated Results of Operations
  26. [26] Item 7, MD&A — Consolidated Results of Operations
  27. [27] Item 7, MD&A — Items Affecting Reported Results, Goodwill Impairment
  28. [28] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  29. [29] Item 7, MD&A — Cash Flows from Operating Activities
  30. [30] Item 7, MD&A — Items Affecting Reported Results, Americas Restructuring Plan
  31. [31] Item 7, MD&A — Items Affecting Reported Results, Americas Restructuring Plan
  32. [32] Item 8, Note 1 — Subsequent Events
  33. [33] Item 7, MD&A — Consolidated Results of Operations, Cost of goods sold
  34. [34] Item 7, MD&A — Global Market Conditions and Competitive Trends
  35. [35] Item 5, Issuer Purchases of Equity Securities
  36. [36] Item 5, Issuer Purchases of Equity Securities
  37. [37] Item 5, Issuer Purchases of Equity Securities
  38. [38] Item 5, Issuer Purchases of Equity Securities
  39. [39] Item 5, Dividends
  40. [40] Item 5, Dividends
  41. [41] Item 8, Note 1 — Subsequent Events
  42. [42] Item 7, MD&A — Capital Expenditures
  43. [43] Item 7, MD&A — Global Market Conditions and Competitive Trends
  44. [44] Item 1A, Risk Factors
  45. [45] Item 1A, Risk Factors
  46. [46] Item 1A, Risk Factors
  47. [47] Item 1A, Risk Factors
  48. [48] Item 7, MD&A — Critical Accounting Estimates, Goodwill
  49. [49] Item 7, MD&A — Global Market Conditions and Competitive Trends
  50. [50] Item 1A, Risk Factors
  51. [51] Item 8, Note 1 — Subsequent Events
  52. [52] Item 8, Consolidated Statements of Operations
  53. [53] Item 8, Consolidated Statements of Operations
  54. [54] Item 8, Consolidated Statements of Operations
  55. [55] Item 8, Consolidated Statements of Operations
  56. [56] Item 8, Consolidated Statements of Operations
  57. [57] Item 8, Consolidated Statements of Operations
  58. [58] Item 8, Consolidated Statements of Operations
  59. [59] Item 8, Consolidated Statements of Operations
  60. [60] Item 8, Consolidated Statements of Operations
  61. [61] Item 8, Consolidated Statements of Operations
  62. [62] Item 8, Consolidated Statements of Cash Flows
  63. [63] Item 8, Consolidated Statements of Cash Flows
  64. [64] Item 8, Consolidated Balance Sheets
  65. [65] Item 8, Consolidated Balance Sheets
  66. [66] Item 8, Consolidated Balance Sheets
  67. [67] Item 8, Consolidated Balance Sheets
  68. [68] Item 7, MD&A — Items Affecting Reported Results, Goodwill Impairment
  69. [69] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  70. [70] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  71. [71] Item 7, MD&A — Items Affecting Reported Results, Intangible Asset Impairment
  72. [72] Item 7, MD&A — Items Affecting Reported Results, Americas Restructuring Plan
  73. [73] Item 7, MD&A — Segment Results of Operations, Americas Segment
  74. [74] Item 7, MD&A — Segment Results of Operations, Americas Segment
  75. [75] Item 7, MD&A — Segment Results of Operations, EMEA&APAC Segment
  76. [76] Item 7, MD&A — Segment Results of Operations, EMEA&APAC Segment

Analysis on 6/21/2026